Member Info for RayPointer

Yes, Wild

Then to end Phil ripped into the lack of funding routes when listed on the Aim market as opposed to Nasdaq.

He didn't pull any punches

Phil is on now!

Thanks Marcus.

What's Eastenders?

IMO, this is nothing to do with leaks.

Instead, it is all about the market finally waking up to the fantastic potential of Scancell.

Violin

"how about funding these companies instead of letting foreign companies buy up UK industry, and it’s not just the biotech sector !"

Maybe because government and the civil service are clueless when it comes to recognising the UK companies that are the future winners.

Next week he might even mention the Scope trial results.

I think they are just far too busy on other things to seek publicity on who is on the advisory board.

But why wouldn't Eric want to be associated with a potential melanoma breakthrough? He probably didn't hesitate too long when approached.

Is it my imagination, but are small birds getting less and less common?

I do have a friendly robin in my garden, but I can't remember the last time a sparrow visited.

GF

Yes, Inan is certainly on form today

Trench

One other way of looking at it is that they want the keep the gravy train moving.

If there is any truth in their statement , then why is the only director investment a paltry £5000?

"saw them on the CNBC moving ticker...which i watch"

Troajan, have you considered taking up train spotting?

More to the point, will there be a Val to invest in?

Anyway, it's lovely to see you posting again, Notpotalot. We all thought you had lost your job.

Sidney

IMO this is just a case of more people waking up to Scancell's near term potential and seeing just how undervalued it is.

Cleaner, I hope you realise that AI is talking about 2 different settings, resected melanoma and unresectable melanoma.

Rc30 and Lemmyy

Lindy and her team have done amazing work to give hope to countless Melanoma patients.

Sadly, too late for your siblings.

It may be time to send in the troops to supress the Chartists. 😂

https://en.wikipedia.org/wiki/Chartism

Wyndrum

Have a look at the Scope trial results and listen to the CEO talking about them.

Try to gauge the potential of Moditope and Glycans and you will realise that Scancell is far from a one-trick pony.

This is not a time to look at technicals.

Sure, it is 100% certain that there will a retrace in the SP at some point but how long before the buying starts again?

Good luck to you, anyway.

Ah, the chief moaner indicator is positive!

"What the diff Wildforce? "

34% actually 😂